Investor buy-side · Entry screen · UK
A crowded £880m market turned into a ranked entry plan.
A flat-looking category concealed double-digit needs-based niches and ten potential targets.
c.£880m market
Needs-based resegmentation
16 expert interviews
Transaction
PE / investor
Consumer health
The challenge
The investor needed to know whether UK vitamins and supplements merited entry, which model could win and which available companies deserved a closer look - without commissioning a full diligence cycle.
The work
The market was resegmented by consumer need rather than product type. Interviews, store and site visits, web traffic and bottom-up P&Ls showed a flat category concealing fast-growth niches - and that advertising and differentiation, not inherited trust, explained brand trajectory.
The result
The review supported a premium, vertically integrated online model focused on needs-based niches, rejected the personalised route and ranked ten targets. Amazon depth and subscription economics remained explicit open risks; the work informed entry, not a transaction.
Engagements were won and led by Elliot Ronald and delivered by teams under his direction at Lion Strategy or its predecessor firm, Hambalt. Client confidentiality is absolute; cases are anonymised except where the work is already on the public record.